BTX vs. ALFIW, CIDM, and NLOK
Should you be buying Brooklyn ImmunoTherapeutics stock or one of its competitors? The main competitors of Brooklyn ImmunoTherapeutics include Alfi (ALFIW), Cinedigm (CIDM), and NortonLifeLock (NLOK). These companies are all part of the "information" sector.
Alfi (NASDAQ:ALFIW) and Brooklyn ImmunoTherapeutics (NYSE:BTX) are both information companies, but which is the better investment? We will compare the two companies based on the strength of their community ranking, dividends, profitability, media sentiment, institutional ownership, risk, analyst recommendations, earnings and valuation.
In the previous week, Brooklyn ImmunoTherapeutics had 1 more articles in the media than Alfi. MarketBeat recorded 1 mentions for Brooklyn ImmunoTherapeutics and 0 mentions for Alfi. Brooklyn ImmunoTherapeutics' average media sentiment score of 0.00 equaled Alfi'saverage media sentiment score.
26.0% of Brooklyn ImmunoTherapeutics shares are owned by institutional investors. 20.5% of Brooklyn ImmunoTherapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Alfi and Brooklyn ImmunoTherapeutics both received 0 outperform votes by MarketBeat users.
Summary
Brooklyn ImmunoTherapeutics beats Alfi on 3 of the 4 factors compared between the two stocks.
Get Brooklyn ImmunoTherapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for BTX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Brooklyn ImmunoTherapeutics Competitors List
Related Companies and Tools
